$4.66 Billion is the total value of SCOPIA CAPITAL MANAGEMENT LP's 41 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 51.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPR | Sell | SPIRIT AEROSYSTEMS HLDGS INC | $720,569,000 | -23.5% | 14,906,259 | -12.8% | 15.46% | -15.5% |
| BIDU | Buy | BAIDU INCspon adr rep a | $377,153,000 | +2.1% | 2,744,728 | +47.9% | 8.09% | +12.8% |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $373,492,000 | +1.7% | 2,845,869 | +34.8% | 8.01% | +12.4% |
| FCEA | Buy | FOREST CITY ENTERPRISES INCcl a | $327,787,000 | -3.8% | 16,283,504 | +5.7% | 7.03% | +6.3% |
| IWM | Sell | ISHARES TRput | $271,821,000 | -29.2% | 2,489,200 | -20.7% | 5.83% | -21.8% |
| SPY | Sell | SPDR S&P 500 ETF TRput | $266,078,000 | -24.7% | 1,388,500 | -17.2% | 5.71% | -16.8% |
| MYGN | Buy | MYRIAD GENETICS INC | $254,236,000 | +15.3% | 6,783,252 | +4.6% | 5.45% | +27.4% |
| ALR | Buy | ALERE INC | $234,109,000 | -1.8% | 4,862,081 | +7.6% | 5.02% | +8.5% |
| VMW | Buy | VMWARE INC | $144,192,000 | -6.1% | 1,830,079 | +2.2% | 3.09% | +3.8% |
| HUN | Buy | HUNTSMAN CORP | $134,408,000 | -50.1% | 13,870,838 | +13.6% | 2.88% | -44.9% |
| BKD | Buy | BROOKDALE SR LIVING INC | $134,109,000 | -8.0% | 5,840,989 | +39.0% | 2.88% | +1.6% |
| CABO | New | CABLE ONE INC | $128,085,000 | – | 305,387 | +100.0% | 2.75% | – |
| MLNX | Buy | MELLANOX TECHNOLOGIES LTD | $117,258,000 | +28.4% | 3,102,880 | +65.1% | 2.52% | +41.8% |
| DST | New | DST SYS INC DEL | $116,576,000 | – | 1,108,765 | +100.0% | 2.50% | – |
| MLCO | Buy | MELCO CROWN ENTMT LTDadr | $107,741,000 | +6.0% | 7,830,047 | +51.3% | 2.31% | +17.1% |
| BCO | Sell | BRINKS CO | $104,634,000 | -10.7% | 3,873,914 | -2.7% | 2.24% | -1.3% |
| BNCL | Buy | BENEFICIAL BANCORP INC | $101,738,000 | +35.5% | 7,672,549 | +27.7% | 2.18% | +49.7% |
| EXPR | Buy | EXPRESS INC | $80,619,000 | +5.5% | 4,511,441 | +7.0% | 1.73% | +16.7% |
| AEGR | Buy | AEGERION PHARMACEUTICALS INC | $77,569,000 | -24.7% | 5,703,587 | +5.1% | 1.66% | -16.8% |
| ZSPH | Buy | ZS PHARMA INC | $65,820,000 | +35.9% | 1,002,444 | +8.4% | 1.41% | +50.1% |
| XLE | Buy | SELECT SECTOR SPDR TRsbi int-energy | $64,486,000 | -14.4% | 1,053,699 | +5.1% | 1.38% | -5.5% |
| ITRI | New | ITRON INC | $61,361,000 | – | 1,922,931 | +100.0% | 1.32% | – |
| SALE | Buy | RETAILMENOT INC | $57,046,000 | -52.2% | 6,923,057 | +3.4% | 1.22% | -47.2% |
| ARPI | Buy | AMERICAN RESIDENTIAL PPTYS I | $54,414,000 | -6.6% | 3,150,754 | +0.0% | 1.17% | +3.1% |
| GNRC | Buy | GENERAC HLDGS INC | $50,296,000 | +1524.0% | 1,671,507 | +2045.7% | 1.08% | +1698.3% |
| INSYQ | Buy | INSYS THERAPEUTICS INC NEW | $48,908,000 | +56.2% | 1,718,487 | +97.1% | 1.05% | +72.5% |
| MLCO | Buy | MELCO CROWN ENTMT LTDcall | $42,666,000 | -32.0% | 3,100,700 | +3.4% | 0.92% | -24.9% |
| New | NEURODERM LTD | $27,771,000 | – | 1,343,541 | +100.0% | 0.60% | – | |
| SGNT | New | SAGENT PHARMACEUTICALS INC | $16,841,000 | – | 1,098,590 | +100.0% | 0.36% | – |
| PSEC | Buy | PROSPECT CAPITAL CORPORATION | $16,093,000 | +2083.6% | 2,257,073 | +2157.1% | 0.34% | +2364.3% |
| GATX | New | GATX CORP | $15,452,000 | – | 349,988 | +100.0% | 0.33% | – |
| ACOR | New | ACORDA THERAPEUTICS INC | $15,039,000 | – | 567,298 | +100.0% | 0.32% | – |
| SLCA | New | U S SILICA HLDGS INC | $11,206,000 | – | 795,341 | +100.0% | 0.24% | – |
| FLDM | New | FLUIDIGM CORP DEL | $10,606,000 | – | 1,307,790 | +100.0% | 0.23% | – |
| QLTI | Buy | QLT INC | $8,874,000 | -26.1% | 3,336,177 | +14.8% | 0.19% | -18.5% |
| LNTH | Buy | LANTHEUS HLDGS INC | $8,335,000 | -23.5% | 1,938,398 | +10.1% | 0.18% | -15.6% |
| AROPQ | Buy | AEROPOSTALE | $6,139,000 | -61.7% | 9,901,969 | +0.0% | 0.13% | -57.7% |
| FOSL | Sell | FOSSIL GROUP INC | $4,017,000 | -42.3% | 71,890 | -28.4% | 0.09% | -36.3% |
| KERX | New | KERYX BIOPHARMACEUTICALS INC | $2,474,000 | – | 702,795 | +100.0% | 0.05% | – |
| New | THERAVANCE INCnote 2.125% 1/1 | $990,000 | – | 1,500,000 | +100.0% | 0.02% | – | |
| AMSC | AMERICAN SUPERCONDUCTOR CORP | $85,000 | -17.5% | 19,610 | 0.0% | 0.00% | 0.0% | |
| KORS | Exit | MICHAEL KORS HLDGS LTD | $0 | – | -41,481 | -100.0% | -0.03% | – |
| ASND | Exit | ASCENDIS PHARMA A Ssponsored adr | $0 | – | -148,114 | -100.0% | -0.05% | – |
| RLYP | Exit | RELYPSA INC | $0 | – | -374,588 | -100.0% | -0.24% | – |
| POST | Exit | POST HLDGS INC | $0 | – | -325,000 | -100.0% | -0.34% | – |
| DAR | Exit | DARLING INGREDIENTS INC | $0 | – | -1,648,980 | -100.0% | -0.47% | – |
| BA | Exit | BOEING COput | $0 | – | -301,900 | -100.0% | -0.84% | – |
| AMH | Exit | AMERICAN HOMES 4 RENTcl a | $0 | – | -3,404,215 | -100.0% | -1.06% | – |
| INFA | Exit | INFORMATICA CORP | $0 | – | -1,149,223 | -100.0% | -1.08% | – |
| TFM | Exit | FRESH MKT INC | $0 | – | -4,448,354 | -100.0% | -2.78% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-11-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPIRIT AEROSYSTEMS HLDGS INC | 39 | Q4 2022 | 28.3% |
| SPDR S&P 500 ETF TR | 31 | Q3 2023 | 16.9% |
| ISHARES TR | 28 | Q3 2023 | 10.9% |
| MANNKIND CORP | 24 | Q3 2023 | 0.5% |
| BAIDU INC | 21 | Q2 2018 | 8.6% |
| ITRON INC | 21 | Q3 2020 | 12.1% |
| RETROPHIN INC | 20 | Q3 2020 | 4.5% |
| HARMONIC INC | 19 | Q3 2023 | 10.5% |
| JOHNSON CTLS INTL PLC | 17 | Q3 2020 | 9.6% |
| ACORDA THERAPEUTICS INC | 17 | Q3 2019 | 4.0% |
View SCOPIA CAPITAL MANAGEMENT LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| VERRA MOBILITY Corp | October 28, 2022 | 6,710,074 | 4.4% |
| Spirit AeroSystems Holdings, Inc. | February 14, 2022 | 2,084,212 | 2.0% |
| Retrophin, Inc. | February 14, 2020 | 2,011,697 | 4.7% |
| Horizon Therapeutics Public Ltd Co | January 10, 2020 | 2,527,456 | 1.4% |
| ZOGENIX, INC. | January 10, 2020 | 919,484 | 2.1% |
| ITRON, INC. | January 07, 2020 | 1,808,059 | 4.6% |
| ACORDA THERAPEUTICS INCSold out | November 12, 2019 | 0 | 0.0% |
| LA JOLLA PHARMACEUTICAL CO | April 10, 2019 | 480,000 | 1.8% |
| Prothena Corp plc | March 11, 2019 | 1,883,816 | 4.7% |
| GW PHARMACEUTICALS PLC | February 14, 2019 | 1,345,198 | 4.6% |
View SCOPIA CAPITAL MANAGEMENT LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D | 2024-04-26 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13D/A | 2024-01-22 |
| 13F-HR/A | 2023-11-14 |
| 13F-HR | 2023-11-14 |
| SC 13D | 2023-09-21 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13D/A | 2023-04-12 |
View SCOPIA CAPITAL MANAGEMENT LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.